Incidence of Mesh Fractures in Open Ventral Hernia Repair with Mediumweight Polypropylene Mesh

This study aims to characterize the occurrence of mesh fractures in open ventral hernia repair using mediumweight polypropylene mesh and identify associated risk factors. The research focuses on patients at Cleveland Clinic from January 2014 to April 2022, emphasizing retromuscular placement and a one-year follow-up. The study excludes minimally invasive approaches, alternative mesh locations, and non-spontaneous mesh fractures.

• Mesh Fractures
• Ventral Hernia Repair
• Mediumweight Mesh
• Risk Factors
• Cleveland Clinic

esti Follow

Uploaded on Aug 19, 2024 | 1 Views

Download Presentation

Please find below an Image/Link to download the presentation.

The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. Download presentation by click this link. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.

Presentation Transcript

1. Mediumweight polypropylene mesh fractures after open retromuscular ventral hernia repair: Incidence and associated risk factors Sara Maskal, MD General Surgery Resident Cleveland Clinic Foundation Co-authors: Benjamin Miller, MD Ryan Ellis, MD Sharon Phillips, MS Ajita Prabhu, MD Lucas Beffa, MD David Krpata, MD Steven Rosenblatt, MD Michael Rosen, MD Clayton Petro, MD

2. Disclosures Study Funding: - none Clayton Petro - BD Consultant - Surgimatix Consultant - Research Grants AHS, CSA, SAGES Ajita Prabhu - Speaking fees and research support paid to institution from Intuitive Surgical - Consulting fees and is on the Advisory Board for CMR Surgical - Consulting fees from Verb Surgical Lucas Beffa - Honoraria from Intuitive Surgical Michael Rosen - Medical director of ACHQC - Stock options with Ariste

3. Background Warren JA, McGrath SP, Hale AL, Ewing JA, Carbonell AM, Cobb WS. Patterns of Recurrence and Mechanisms of Failure after Open Ventral Hernia Repair with Mesh. Am Surg. 2017;83(11):1275-1282. doi:10.1177/000313481708301131

4. Background Definitions of weight: - Lightweight (<40 g/m2) - Mediumweight (40-60 g/m2) - Intermediate weight (60- 75 g/m2) - Heavyweight (>75 g/m2) Krpata DM, Petro CC, Prabhu AS, et al. Effect of Hernia Mesh Weights on Postoperative Patient-Related and Clinical Outcomes After Open Ventral Hernia Repair: A Randomized Clinical Trial. JAMA Surg. 2021;156(12):1085 1092. doi:10.1001/jamasurg.2021.4309

5. Background Are mesh fractures common enough that we should abandon mediumweight mesh?

6. Specific Aims Characterize the incidence of mesh fractures in OVHR with mediumweight polypropylene (MWPP) Identify associated risk factors

7. METHODS

8. Mesh fracture definition

9. Inclusion/Exclusion Criteria Inclusion - Adult patients - Open ventral hernia repair - Retromuscular placement of MWPP - Cleveland Clinic, January 2014 to April 2022 - At least 1-year follow-up Exclusion - MIS approach - Alternative mesh locations - Non-spontaneous mesh fracture - No imaging or operative reports available

10. Comparators Patients with a mesh fracture Blinded consensus CT review or operative note Patients without a recurrence Negative HRI, CT, or surgeon entered follow up

11. Variables Variables Demographics Operative details SSI SSO SSOPI Reoperation

12. RESULTS

13. Mesh fracture rate: 28/672 (4.2%)

14. Patient Demographics & Comorbidities No mesh fracture (N=644) Mesh fracture (N=28) Test statistic Sex, % Female (N) Race, % White (N) Age, years (median, IQR) BMI, kg/m2 (median, IQR) Active Smoker, % (N) 55% (352) 43% (12) p=0.22 92.5% (594) 61(52-69) 32 (28-36) 23% (34) 85.7% (24) 58 (47-63) 34 (29-36) 12% (1) p=0.19 p=0.12 p=0.27 p=0.59 Comorbidities Ascites Diabetes Dialysis COPD Anti-platelet use Anticoagulant use Immunosuppression History of AAA Recurrent hernia Current active infection 0.34% (2) 20% (128) 0.93% (6) 11% (69) 10% (67) 7% (45) 8.5% (55) 2.3% (15) 55% (356) 2.8% (18) 0% (0) 25% (7) 3.57% (1) 14% (4) 0% (0) 7.1% (2) 28.6% (8) 0% (0) 61% (17) 0% (0) p=0.76 p=0.51 p=0.18 p=0.55 p=0.072 p=0.98 p<0.001 p=0.61 p=0.57 p=0.37

15. Operative Details No mesh fracture 99.38% (640) Mesh fracture 96.43% (27) p p=0.08 Elective case, % (N) 15 (12-18) 23 (19-26) 900 (900-1600) 83.7% (539) 23% (147) 5.3% (34) 25 (23-30) 25 (23-30) 900 (900-2500) 92.6% (25) 18% (5) 11% (3) p<0.001 p=0.004 p=0.01 p=0.22 p=0.54 p=0.19 p=0.69 Hernia Width (median [IQR], cm) Hernia Length (median [IQR], cm) Mesh Area (median [IQR], cm2) Mesh Fixation % Concomitant Procedure Intraoperative Complications CDC wound status, % (N) Clean Clean-contaminated Contaminated Dirty/infected Bridged closure, %(N) 69.41% (447) 14.6% (94) 15.9% (101) 0.31% (2) 3.3% (21) 78.6 % (22) 7.1% (2) 14.3% (4) 0% (0) 33.3% (9) p<0.001

16. Short-Term Clinical Outcomes No mesh fracture 3.1% (20) 37% (238) 8.9% (57) 12.3% (79) 11% (73) Mesh fracture 3.6% ( 1) 54% (15) 17.9% (5) 7.1% (2) 14% (4) Test statistic p=0.89 p=0.08 p=0.11 p=0.41 p=0.50 Reoperation Post-operative complications (any) Surgical site infection (SSI) Surgical site occurrences (SSO) SSI/SSO requiring procedural intervention

17. Summary Incidence of mesh fractures with MWPP is alarmingly high (4.2%) - At our center: 400 complex reconstructions =12 central mesh failures/year Anterior fascial bridging has a fracture rate of 30%! - 10x higher risk than if fascial closure is obtained

18. Conclusions Surgeons should be aware of MWPP vulnerability to fracture and weigh risks/benefits Industry should be aware of the blind spot in today s synthetic mesh market - Larger pieces of HW mesh and/or a macroporous HW alternative

19. Thank you!